<DOC>
	<DOC>NCT02046499</DOC>
	<brief_summary>This is a randomized trial comparing oxytocin versus oxytocin + syntometrine in the prevention of post partum haemorrhage in patients undergoing caesarean section</brief_summary>
	<brief_title>A Randomized Trial Comparing Oxytocin and Oxytocin + Ergometrine for Prevention of Postpartum Haemorrhage at Caesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Syntometrine</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>Pregnant women delivering by caesarean section older than 18 years willing and able to give informed consent • Women not willing or women not able to provide consent Women who have a classical caesarean section Women younger than 18 years of age Women with any of the following conditions will be excluded (ergometrine contraindicated in patients with these conditions). Pre eclampsia Eclampsia, Uncontrolled hypertension (hypertension defined as systolic blood pressure more than 140 mm Hg and diastolic blood pressure more than 90 mm Hg) Any cardiac lesion Impaired liver function Impaired kidney function Hypersensitivity to any of the active ingredients of the preparations that will be used (Syntometrine® or Syntocinon®) Occlusive vascular disease Autoimmune vasculitis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Prevention, post partum haemorrhage</keyword>
</DOC>